User profiles for M Dicuio

Mauro Dicuio

urologist Ospedale Maggiore di Bologna
Verified email at ausl.bologna.it
Cited by 671

Sexual dysfunction in subjects treated with inhibitors of 5α‐reductase for benign prostatic hyperplasia: a comprehensive review and meta‐analysis

…, M Gacci, M Dicuio, A Sforza, E Mannucci, M Maggi - …, 2017 - Wiley Online Library
Despite their efficacy in the treatment of benign prostatic hyperplasia, the popularity of inhibitors
of 5α‐reductase (5 ARI s) is limited by their association with adverse sexual side effects. …

Testosterone treatment and cardiovascular and venous thromboembolism risk: what is 'new'?

G Corona, M Dicuio, G Rastrelli… - Journal of …, 2017 - journals.sagepub.com
In men, testosterone (T) production declines as a function of ageing. Late-onset hypogonadism
(LOH) is the most commonly used term to indicate this age-related condition. In LOH, the …

Sexual function in men undergoing androgen deprivation therapy

…, P Comelio, N Bianchi, F Frizza, M Dicuio… - International Journal of …, 2021 - nature.com
Androgen deprivation therapy (ADT) has a deleterious effect on sexual functions and general
well-being in men. Despite this evidence, however, patient and couple knowledge about …

Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms

S Vesely, T Knutson, JE Damber, M Dicuio… - … journal of urology …, 2003 - Taylor & Francis
Objectives: To estimate the relationship between age and the values of different diagnostic
tests in men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic …

[PDF][PDF] Measurements of urinary bladder volume: comparison of five ultrasound calculation methods in volunteers

M Dicuio, G Pomara, F Menchini Fabris, V Ales… - Arch Ital Urol …, 2005 - researchgate.net
Stesura Dicuio 3 Page 1 MATERIALS AND METHODS Ten healthy young medical staff
volunteers (male and female) without prior urological problems were examined two times with a …

[HTML][HTML] Cardiovascular risks of androgen deprivation therapy for prostate cancer

G Corona, S Filippi, N Bianchi, M Dicuio… - The World Journal of …, 2021 - ncbi.nlm.nih.gov
Androgen deprivation therapy (ADT) is the gold standard treatment in patients with locally
advanced or metastatic prostate cancer (PC). Emerging evidence has documented a tight …

Cardiovascular parameter changes in patients with erectile dysfunction using PDE‐5 inhibitors: A study with sildenafil and vardenafil

…, N Dinelli, F Travaglini, M Dicuio… - Journal of …, 2004 - Wiley Online Library
Sildenafil is the most prescribed oral agent for patients with erectile dysfunction (ED). Vardenafil
is a new phosphodiesterase type 5 (Pde‐5) inhibitor that was approved by the US Food …

Subclinical male hypogonadism.

…, G Rastrelli, M Dicuio, S Concetti, M Minnetti… - Minerva …, 2020 - europepmc.org
Conclusions Although available evidence suggests that in aging populations SHG can be
considered a particular condition associated with an increased CV risk, it is still unknown if …

[PDF][PDF] The use of prostatic intravesical protrusion correlated with uroflowmetry: a new method to measure obstruction in patients with LUTS due to BOO without using P …

M Dicuio, G Pomara, S Vesely, G Morelli… - Arch Ital Urol …, 2005 - researchgate.net
Stesura Dicuio 2 Page 1 performed, qualified operator and it is an invasive method, but it is
the only nowadays available to detect obstruction. In the assessment of BOO, pressure-flow …

Transurethral microwave thermotherapy: clinical results after 11 years of use

S Vesely, T Knutson, M Dicuio, JE Damber… - Journal of …, 2005 - liebertpub.com
Purpose: To evaluate the durability of the effect of transurethral microwave thermotherapy (TUMT)
for lower urinary-tract symptoms (LUTS) suggestive of bladder outlet obstruction (BOO)…